<DOC>
	<DOCNO>NCT00821587</DOCNO>
	<brief_summary>The purpose study evaluate effect cyclosporine , anti-rejection drug , clearance hepatitis C virus liver transplant subject treat peg-interferon ribavirin .</brief_summary>
	<brief_title>Cyclosporine Hepatitis C Infection Viral Clearance Following Liver Transplantation</brief_title>
	<detailed_description>This randomize , single-center control study compare two different immunosuppression regimen ( CsA TAC ) patient recurrent HCV LT undergo antiviral therapy HCV .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Virus Diseases</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<criteria>Males female age 18 year old HCV RNA positive PCR liver transplantation Elevated ALT time point liver transplantation Protocol liver biopsy ( standard care ) consistent Stage great equal 2 Ishak fibrosis score liver transplantation Able provide write informed consent Willing practice acceptable birth control study period . Decompensated Cirrhosis hemoglobin &lt; 12 g/dl WBC &lt; 3,500/cubic mm Platelets &lt; 75,000/cubic mm Human immunodeficiency virus infection Pregnancy Positive HbsAg History coronary artery disease , history seizure disorder , poorly control autoimmune condition , thyroid dysfunction , diabetes mellitus , major psychosis , intolerance previous interferonbased therapy anemia neutropenia History suicidal ideation suicidal attempt Creatinine &gt; 2.0 mg/dl Severe nonhepatic illness</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Hepatitis C Post Liver Transplant</keyword>
</DOC>